Eric Spencer, MD
Orthopaedic Surgery · Yonkers, NYNPI 1245219856
Payments from drug & device makers
Across 80 payments — averaging $23.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$377
- Amgen$185
- Ferring Pharmaceuticals Inc.$180
- Endo Pharmaceuticals Inc.$176
- Fidia Pharma USA Inc.$103
- Johnson & Johnson$97
- plus $728 from 17 others
What the payments were for
- Food & beverage$1,846100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 12 | $377 |
| Amgen | 11 | $185 |
| Ferring Pharmaceuticals Inc. | 10 | $180 |
| Endo Pharmaceuticals Inc. | 9 | $176 |
| Fidia Pharma USA Inc. | 6 | $103 |
| Johnson & Johnson | 4 | $97 |
| Zimmer Biomet | 2 | $93 |
| Pacira Pharmaceuticals Incorporated | 3 | $83 |
| Endo USA, Inc. | 4 | $83 |
| ERMI LLC | 1 | $68 |
| Gotham Surgical Solutions & Devices, Inc. | 2 | $64 |
| Acelrx Pharmaceuticals, Inc. | 4 | $54 |
| Bioventus LLC | 1 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Orthofix Medical, Inc. | 1 | $33 |
| Pacira Therapeutics, Inc. | 1 | $29 |
| Boston Scientific | 1 | $28 |
| AbbVie | 1 | $25 |
| Smith+Nephew | 1 | $19 |
| Pfizer | 1 | $19 |
| Abbott | 1 | $19 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
| Axogen | 1 | $15 |
How this compares
$1,846 in reported general payments places this provider in the 35th percentile of 1,079 orthopaedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $159 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $123 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 33 | $98 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Yonkers
- Anthony RomeoNew York$27M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$14.1M
- William RicciNew York$11.6M
- Steven HaasNew York$11.5M
- Giles ScuderiNew York$10.9M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.